Clinical Cancer Research, Vol 4, Issue 5 1273-1278, Copyright © 1998 by American Association for Cancer Research

ARTICLES

A similar pattern of chromosomal alterations in prostate cancers from African-Americans and Caucasian Americans

ML Cher, PE Lewis, M Banerjee, PM Hurley, W Sakr, DJ Grignon and IJ Powell
Department of Urology, Wayne State University School of Medicine, Detroit, Michigan 48201, USA. mcher@med.wayne.edu

A combination of genetic and epigenetic factors may explain the disproportionate incidence and mortality of prostate cancer among African-American males (AAMs) as compared with Caucasian American males (CAMs). We wished to determine whether primary prostate cancers from AAMs and CAMs harbor different patterns or frequencies of chromosomal alterations. Comparative genomic hybridization (CGH) was performed on clinically localized, untreated primary prostate cancers from 16 AAMs and 16 CAMs. Detailed statistical analysis was used to delineate gains and deletions with high sensitivity and specificity and to compare the frequency and pattern of alterations between the two groups of tumors. The two groups of patients had indistinguishable preoperative serum prostate-specific antigen levels, and the two groups of tumors had similar pathological stages and grades. Chromosomal gains and deletions occurred in regions known to be frequently altered in prostate cancer. Specifically, the most frequent alterations were deletions of regions on chromosomes 13q, 5q, 16q, and 8p and gains of regions on 8q and 5q. When tumors from AAMs and CAMs were compared, the frequencies of alteration (deletion, gain, or no alteration) were similar across 98.9% of the length of the genome. The patterns of alterations of the most frequently altered chromosomes were also similar between tumors from AAMs and CAMs. We concluded that primary prostate cancers from AAMs and CAMs harbor a similar pattern and frequency of chromosomal alterations. These data support the notion that sporadic prostate cancers from AAMs and CAMs develop by similar chromosomal mechanisms. Biological differences, if present, do not occur on the chromosomal level.

This article has been cited by other articles:

				T. A. Wallace, R. L. Prueitt, M. Yi, T. M. Howe, J. W. Gillespie, H. G. Yfantis, R. M. Stephens, N. E. Caporaso, C. A. Loffredo, and S. Ambs Tumor Immunobiological Differences in Prostate Cancer between African-American and European-American Men Cancer Res., February 1, 2008; 68(3): 927 - 936. [Abstract] [Full Text] [PDF]

				H. Matsuyama, Y. Pan, K. Oba, S. Yoshihiro, K. Matsuda, L. Hagarth, D. Kudren, K. Naito, U. S. R. Bergerheim, and P. Ekman Deletions on Chromosome 8p22 May Predict Disease Progression As Well As Pathological Staging in Prostate Cancer Clin. Cancer Res., October 1, 2001; 7(10): 3139 - 3143. [Abstract] [Full Text] [PDF]

				J. A. Nemeth, J. F. Harb, U. Barroso Jr., Z. He, D. J. Grignon, and M. L. Cher Severe Combined Immunodeficient-hu Model of Human Prostate Cancer Metastasis to Human Bone Cancer Res., April 1, 1999; 59(8): 1987 - 1993. [Abstract] [Full Text] [PDF]